X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-03-03 | BLI | Berkeley Lights, Inc. | Rothman James | Dir | S - Sale+OE | $58.61 | -96,155 | 278,845 | -26% | -$5,635,372 | |||||
2021-03-03 | BLI | Berkeley Lights, Inc. | Marks Michael E | Dir | S - Sale | $61.54 | -1,740 | 1,272,402 | 0% | -$107,083 | ||||||
2021-03-02 | ILMN | Illumina, Inc. | Flatley Jay T | Dir | S - Sale | $444.61 | -4,000 | 172,433 | -2% | -$1,778,440 | ||||||
| M | 2021-03-01 | BLI | Berkeley Lights, Inc. | Marks Michael E | Dir | S - Sale | $62.33 | -40,000 | 1,274,142 | -3% | -$2,493,069 | |||||
| M | 2021-03-01 | BLI | Berkeley Lights, Inc. | Breinlinger Keith | Chief Technical Officer | S - Sale | $61.71 | -13,550 | 41,450 | -25% | -$836,177 | |||||
| D | 2021-03-01 | BLI | Berkeley Lights, Inc. | Hobbs Eric | CEO | S - Sale+OE | $61.34 | -203,967 | 0 | -100% | -$12,511,900 | |||||
| DM | 2021-03-01 | BLI | Berkeley Lights, Inc. | Rosinack Matthew W. | SVP, Chief Accounting Officer | S - Sale+OE | $62.07 | -21,000 | 16,250 | -56% | -$1,303,434 | |||||
| D | 2021-03-01 | BLI | Berkeley Lights, Inc. | Holt Shaun | CFO | S - Sale+OE | $61.56 | -12,300 | 0 | -100% | -$757,161 | |||||
| D | 2021-03-01 | BLI | Berkeley Lights, Inc. | Boyce Sarah | Dir | S - Sale+OE | $61.13 | -10,000 | 0 | -100% | -$611,337 | |||||
| D | 2021-03-01 | BLI | Berkeley Lights, Inc. | Merkadeau Stuart L | GC | S - Sale+OE | $61.57 | -8,878 | 153,622 | -5% | -$546,580 | |||||
2021-03-01 | PRPO | Precipio, Inc. | Danieli Ilan | CEO | P - Purchase | $2.46 | +1,025 | 21,462 | +5% | +$2,522 | ||||||
2021-03-02 | AVTR | Avantor, Inc. | Wondrasch Michael | EVP, CIO | S - Sale | $28.71 | -3,036 | 145,438 | -2% | -$87,164 | ||||||
2021-03-01 | TXG | 10X Genomics, Inc. | Stuelpnagel John R | Dir | S - Sale | $183.19 | -7,500 | 450,991 | -2% | -$1,373,887 | ||||||
2021-03-01 | QTRX | Quanterix Corp | Mattoon Dawn | SVP, Research Products | S - Sale | $81.33 | -217 | 33,425 | -1% | -$17,648 | ||||||
2021-03-01 | QTRX | Quanterix Corp | Chaubal Amol | CFO | S - Sale | $81.33 | -166 | 30,565 | -1% | -$13,500 | ||||||
2021-03-01 | QTRX | Quanterix Corp | Hrusovsky E Kevin | COB, Pres, CEO | S - Sale | $81.33 | -3,443 | 999,000 | 0% | -$280,014 | ||||||
2021-03-01 | QTRX | Quanterix Corp | Fry John J | GC, Secretary | S - Sale | $81.33 | -202 | 35,033 | -1% | -$16,428 | ||||||
2021-03-01 | QTRX | Quanterix Corp | Roskey Mark T. | SVP, Commercial, Accelerator | S - Sale | $81.33 | -137 | 24,572 | -1% | -$11,142 | ||||||
| D | 2021-02-26 | PACB | Pacific Biosciences of California, Inc. | Hunkapiller Michael | Dir | S - Sale+OE | $31.02 | -234,246 | 848,405 | -22% | -$7,265,866 | |||||
| DM | 2021-02-24 | PACB | Pacific Biosciences of California, Inc. | Hunkapiller Michael | Dir | S - Sale+OE | $34.30 | -605,804 | 848,405 | -42% | -$20,778,225 | |||||
2021-02-24 | AVTR | Avantor, Inc. | Brophy Gerard | EVP, Biopharma Production | S - Sale | $27.93 | -3,059 | 172,384 | -2% | -$85,438 | ||||||
| DM | 2021-02-22 | PACB | Pacific Biosciences of California, Inc. | Hunkapiller Michael | Dir | S - Sale+OE | $36.50 | -602,448 | 848,405 | -42% | -$21,989,724 | |||||
2021-02-22 | PACB | Pacific Biosciences of California, Inc. | Schaefer Eric | Chief Accounting Officer | S - Sale | $39.20 | -3,842 | 88,474 | -4% | -$150,606 | ||||||
2021-02-22 | A | Agilent Technologies, Inc. | Gonsalves Rodney | VP, Corporate Controller | S - Sale | $124.17 | -5,000 | 41,229 | -11% | -$620,850 | ||||||
| D | 2021-02-22 | AVTR | Avantor, Inc. | Brophy Gerard | EVP, Biopharma Production | S - Sale+OE | $28.62 | -19,769 | 175,443 | -10% | -$565,789 | |||||
2021-02-19 | QTRX | Quanterix Corp | Chaubal Amol | CFO | S - Sale | $90.33 | -733 | 30,423 | -2% | -$66,212 | ||||||
2021-02-19 | QTRX | Quanterix Corp | Roskey Mark T. | SVP, Commercial, Accelerator | S - Sale | $90.33 | -670 | 24,435 | -3% | -$60,523 | ||||||
2021-02-19 | QTRX | Quanterix Corp | Fry John J | GC, Secretary | S - Sale | $90.33 | -871 | 34,530 | -2% | -$78,680 | ||||||
2021-02-19 | QTRX | Quanterix Corp | Mattoon Dawn | SVP, Research Products | S - Sale | $90.33 | -871 | 33,642 | -3% | -$78,680 | ||||||
2021-02-18 | ILMN | Illumina, Inc. | McGinnis Karen K | VP, Chief Accounting Officer | S - Sale | $486.75 | -666 | 1,538 | -30% | -$324,176 | ||||||
| M | 2021-02-18 | QTRX | Quanterix Corp | Hrusovsky E Kevin | COB, Pres, CEO | S - Sale | $86.40 | -8,493 | 1,002,443 | -1% | -$733,791 | |||||
| D | 2021-02-19 | BIOBI | Bio-Rad Laboratories, Inc. | Ernst Timothy S | EVP, GC, Sec | S - Sale+OE | $640.77 | -923 | 1,220 | -43% | -$591,499 | |||||
| D | 2021-02-17 | SEER | Seer, Inc. | Farokhzad Omid | CEO, Chair of the Board, 10% | S - Sale+OE | $64.15 | -354,741 | 384,487 | -48% | -$22,756,635 | |||||
| D | 2021-02-17 | TLIS | Talis Biomedical Corp | Popovits Kimberly J | Dir | P - Purchase | $16.00 | +5,300 | 422,891 | +1% | +$84,800 | |||||
| D | 2021-02-17 | TLIS | Talis Biomedical Corp | Scott Randal W. | Dir | P - Purchase | $16.00 | +312,500 | 1,702,564 | +22% | +$5,000,000 | |||||
| D | 2021-02-17 | TLIS | Talis Biomedical Corp | Baker Bros. Advisors LP | Dir, 10% | P - Purchase | $16.00 | +6,250,000 | 7,003,766 | +829% | +$100,000,000 | |||||
2021-02-17 | TLIS | Talis Biomedical Corp | Ramakrishnan Ramesh | SVP, R, D | P - Purchase | $16.00 | +1,000 | 1,000 | New | +$16,000 | ||||||
2021-02-17 | TLIS | Talis Biomedical Corp | Posard Matthew L. | Dir | P - Purchase | $16.00 | +62,500 | 62,500 | New | +$1,000,000 | ||||||
2021-02-17 | TLIS | Talis Biomedical Corp | Moody John Roger Jr | CFO | P - Purchase | $16.00 | +1,700 | 1,700 | New | +$27,200 | ||||||
2021-02-17 | TLIS | Talis Biomedical Corp | Liu Douglas | SVP, Operations | P - Purchase | $16.00 | +4,000 | 4,000 | New | +$64,000 | ||||||
2021-02-17 | TLIS | Talis Biomedical Corp | Flick Karen E. | Chief of Staff, SVP, Legal | P - Purchase | $16.00 | +2,000 | 2,000 | New | +$32,000 | ||||||
2021-02-18 | MTD | Mettler Toledo International Inc/ | Chu Wah-Hui | Dir | S - Sale | $1,218.00 | -14 | 3,206 | 0% | -$17,052 | ||||||
2021-02-17 | MTD | Mettler Toledo International Inc/ | Kaltenbach Patrick | CEO Designate | P - Purchase | $1,170.00 | +50 | 1,266 | +4% | +$58,500 | ||||||
| D | 2021-02-16 | PACB | Pacific Biosciences of California, Inc. | Ordonez Kathy | Dir | S - Sale+OE | $47.99 | -220,771 | 21,875 | -91% | -$10,595,810 | |||||
2021-02-16 | ILMN | Illumina, Inc. | Flatley Jay T | Dir | S - Sale | $504.13 | -4,500 | 176,433 | -2% | -$2,268,583 | ||||||
| M | 2021-02-16 | A | Agilent Technologies, Inc. | Tang Michael | SVP, GC,, Sec. | S - Sale | $131.16 | -1,000 | 53,530 | -2% | -$131,155 | |||||
2021-02-16 | A | Agilent Technologies, Inc. | McMullen Michael R. | CEO, Pres | S - Sale | $130.00 | -20,766 | 294,219 | -7% | -$2,699,580 | ||||||
| DM | 2021-02-16 | A | Agilent Technologies, Inc. | Grau Dominique | SVP | S - Sale+OE | $133.59 | -19,786 | 81,326 | -20% | -$2,643,281 | |||||
2021-02-16 | TXG | 10X Genomics, Inc. | Stuelpnagel John R | Dir | S - Sale | $193.00 | -7,500 | 458,491 | -2% | -$1,447,516 | ||||||
| D | 2021-02-16 | MTD | Mettler Toledo International Inc/ | Keller Gerry | Head of Process Analytics | S - Sale+OE | $1,192.01 | -878 | 219 | -80% | -$1,046,585 | |||||
2021-02-12 | PACB | Pacific Biosciences of California, Inc. | Shapiro Lucy | Dir | S - Sale | $50.40 | -101,666 | 0 | -100% | -$5,123,966 | ||||||
| D | 2021-02-12 | PACB | Pacific Biosciences of California, Inc. | Livingston Randall S | Dir | S - Sale+OE | $48.07 | -67,500 | 0 | -100% | -$3,244,455 | |||||
| D | 2021-02-12 | PACB | Pacific Biosciences of California, Inc. | Botstein David | Dir | S - Sale+OE | $49.62 | -160,000 | 0 | -100% | -$7,939,764 | |||||
| D | 2021-02-12 | MTD | Mettler Toledo International Inc/ | Magloth Christian | Head of HR | S - Sale+OE | $1,216.10 | -500 | 124 | -80% | -$608,050 | |||||
| D | 2021-02-12 | MTD | Mettler Toledo International Inc/ | Chu Wah-Hui | Dir | S - Sale+OE | $1,218.00 | -37 | 3,220 | -1% | -$45,066 | |||||
2021-02-11 | MTD | Mettler Toledo International Inc/ | De La Guerroniere Marc | Head of Eur, NA Market Orgs. | S - Sale | $1,202.28 | -6,000 | 6,943 | -46% | -$7,213,662 | ||||||
2021-02-11 | QTRX | Quanterix Corp | Duffy David C. | SVP R, D, CTO | S - Sale | $79.62 | -1,667 | 39,952 | -4% | -$132,727 | ||||||
| D | 2021-02-10 | MTD | Mettler Toledo International Inc/ | Spoerry Robert F | Dir | S - Sale+OE | $1,220.00 | -1,000 | 238,125 | 0% | -$1,220,000 | |||||
| D | 2021-02-09 | MTD | Mettler Toledo International Inc/ | Magloth Christian | Head of HR | S - Sale+OE | $1,212.14 | -1,000 | 124 | -89% | -$1,212,140 | |||||
| D | 2021-02-09 | MTD | Mettler Toledo International Inc/ | Filliol Oliver A | Pres, CEO | S - Sale+OE | $1,211.41 | -5,000 | 18,531 | -21% | -$6,057,027 | |||||
| D | 2021-02-09 | QTRX | Quanterix Corp | Hrusovsky E Kevin | COB, Pres, CEO | S - Sale+OE | $78.18 | -5,000 | 1,010,936 | 0% | -$390,887 | |||||
| D | 2021-02-09 | WAT | Waters Corp /de/ | Reed Joann A | Dir | S - Sale+OE | $282.39 | -4,759 | 39,685 | -11% | -$1,343,909 | |||||
| D | 2021-02-08 | MTD | Mettler Toledo International Inc/ | Salice Thomas P | Dir | S - Sale+OE | $1,193.00 | -1,484 | 64,846 | -2% | -$1,770,412 | |||||
| D | 2021-02-08 | MTD | Mettler Toledo International Inc/ | Spoerry Robert F | Dir | S - Sale+OE | $1,200.00 | -1,000 | 238,125 | 0% | -$1,200,000 | |||||
| D | 2021-02-08 | MTD | Mettler Toledo International Inc/ | Vadala Shawn | CFO | S - Sale+OE | $1,194.00 | -1,287 | 4,900 | -21% | -$1,536,678 | |||||
2021-02-05 | ILMN | Illumina, Inc. | Tousi Susan H | SVP Product Development | S - Sale | $431.90 | -800 | 39,713 | -2% | -$345,520 | ||||||
| D | 2021-02-05 | AVTR | Avantor, Inc. | Wondrasch Michael | EVP, CIO | S - Sale+OE | $29.77 | -49,468 | 141,543 | -26% | -$1,472,662 | |||||
2021-02-01 | SEER | Seer, Inc. | Invus Public Equities, L.P. | 10% | S - Sale | $64.15 | -252,545 | 5,588,366 | -4% | -$16,201,519 | ||||||
| D | 2021-02-01 | SEER | Seer, Inc. | Farokhzad Omid | CEO, Chair of the Board, 10% | S - Sale+OE | $64.15 | -1,089,279 | 384,487 | -74% | -$69,877,248 | |||||
2021-02-01 | TXG | 10X Genomics, Inc. | Stuelpnagel John R | Dir | S - Sale | $176.05 | -7,500 | 465,991 | -2% | -$1,320,380 | ||||||
| D | 2021-02-01 | TXG | 10X Genomics, Inc. | Saxonov Serge | CEO, 10% | S - Sale+OE | $176.00 | -10,000 | 880,468 | -1% | -$1,760,043 | |||||
| D | 2021-02-01 | TXG | 10X Genomics, Inc. | McAnear Justin J. | CFO | S - Sale+OE | $176.05 | -10,000 | 20,774 | -32% | -$1,760,479 | |||||
2021-02-01 | TXG | 10X Genomics, Inc. | Hindson Benjamin J. | See Remarks, 10% | S - Sale | $175.98 | -33,750 | 36,636 | -48% | -$5,939,456 | ||||||
| D | 2021-02-01 | TXG | 10X Genomics, Inc. | Crutchfield Bradford | Chief Commercial Officer | S - Sale+OE | $175.99 | -17,000 | 34,608 | -33% | -$2,991,765 | |||||
2021-02-02 | ILMN | Illumina, Inc. | Hoyt Aimee L | SVP, Chief People Officer | S - Sale | $444.84 | -57 | 2,359 | -2% | -$25,356 | ||||||
2021-02-02 | ILMN | Illumina, Inc. | Flatley Jay T | Dir | S - Sale | $444.84 | -4,000 | 180,933 | -2% | -$1,779,360 | ||||||
2021-02-02 | ILMN | Illumina, Inc. | McGinnis Karen K | VP, Chief Accounting Officer | S - Sale | $444.84 | -72 | 1,538 | -4% | -$32,028 | ||||||
2021-02-01 | ILMN | Illumina, Inc. | Desouza Francis A | Pres, CEO | S - Sale | $439.78 | -3,000 | 52,603 | -5% | -$1,319,330 | ||||||
| D | 2020-12-17 | AXDX | Accelerate Diagnostics, Inc | Reichling Steven | CFO | S - Sale+OE | $7.37 | -859 | 15,583 | -5% | -$6,331 | |||||
| D | 2020-12-17 | AXDX | Accelerate Diagnostics, Inc | Price Ron | Head of Commercial Operations | S - Sale+OE | $7.37 | -727 | 1,874 | -28% | -$5,358 | |||||
| D | 2021-02-02 | AXDX | Accelerate Diagnostics, Inc | Phillips Jack | CEO | S - Sale+OE | $10.90 | -3,313 | 10,508 | -24% | -$36,112 | |||||
| D | 2020-12-17 | AXDX | Accelerate Diagnostics, Inc | Phillips Jack | CEO | S - Sale+OE | $7.37 | -1,542 | 3,821 | -29% | -$11,365 | |||||
| M | 2021-02-01 | A | Agilent Technologies, Inc. | McMullen Michael R. | CEO, Pres | S - Sale | $122.57 | -63,190 | 314,985 | -17% | -$7,745,187 | |||||
2021-02-01 | QTRX | Quanterix Corp | Mattoon Dawn | SVP, Research Products | S - Sale | $68.26 | -182 | 30,834 | -1% | -$12,423 | ||||||
2021-02-01 | QTRX | Quanterix Corp | Hrusovsky E Kevin | COB, Pres, CEO | S - Sale | $66.77 | -8,249 | 997,539 | -1% | -$550,788 | ||||||
2021-02-01 | QTRX | Quanterix Corp | Chaubal Amol | CFO | S - Sale | $68.26 | -133 | 25,367 | -1% | -$9,078 | ||||||
2021-02-01 | QTRX | Quanterix Corp | Fry John J | GC, Secretary | S - Sale | $68.26 | -163 | 31,722 | -1% | -$11,126 | ||||||
2021-02-01 | QTRX | Quanterix Corp | Roskey Mark T. | SVP, Commercial, Accelerator | S - Sale | $68.26 | -105 | 21,732 | 0% | -$7,167 | ||||||
| D | 2021-02-01 | PKI | Perkinelmer Inc | Tereau Daniel R | Please See Remarks | S - Sale+OE | $147.07 | -2,047 | 9,071 | -18% | -$301,052 | |||||
2021-01-29 | AXDX | Accelerate Diagnostics, Inc | Schuler Jack W | Dir, 10% | P - Purchase | $10.18 | +30,868 | 17,711,415 | 0% | +$314,236 | ||||||
| DM | 2020-04-21 | TXG | 10X Genomics, Inc. | Paladin Capital Management, LLC | 10% | S - Sale+OE | $78.25 | -1,000,568 | 5,617,583 | -15% | -$78,292,305 | |||||
| DM | 2021-01-25 | AXDX | Accelerate Diagnostics, Inc | Reichling Steven | CFO | S - Sale+OE | $12.90 | -70,671 | 13,300 | -84% | -$911,654 | |||||
| D | 2021-01-25 | PACB | Pacific Biosciences of California, Inc. | Hunkapiller Michael | Dir | S - Sale+OE | $36.34 | -125,406 | 848,405 | -13% | -$4,556,901 | |||||
2021-01-25 | QTRX | Quanterix Corp | Hrusovsky E Kevin | COB, Pres, CEO | S - Sale | $77.81 | -5,000 | 1,005,788 | 0% | -$389,056 | ||||||
| DM | 2021-01-20 | PACB | Pacific Biosciences of California, Inc. | Hunkapiller Michael | Dir | S - Sale+OE | $37.53 | -624,404 | 848,405 | -42% | -$23,430,830 | |||||
2021-01-22 | QTRX | Quanterix Corp | Duffy David C. | SVP R, D, CTO | S - Sale | $79.29 | -1,667 | 39,473 | -4% | -$132,176 | ||||||
2021-01-19 | QTRX | Quanterix Corp | Hrusovsky E Kevin | COB, Pres, CEO | S - Sale | $74.53 | -5,000 | 1,010,788 | 0% | -$372,646 | ||||||
2021-01-20 | ILMN | Illumina, Inc. | Tousi Susan H | SVP Product Development | S - Sale | $400.00 | -2,500 | 40,447 | -6% | -$1,000,000 | ||||||
2021-01-19 | ILMN | Illumina, Inc. | Flatley Jay T | Dir | S - Sale | $382.48 | -4,000 | 184,933 | -2% | -$1,529,920 | ||||||
2021-01-19 | TXG | 10X Genomics, Inc. | Stuelpnagel John R | Dir | S - Sale | $178.76 | -7,500 | 473,491 | -2% | -$1,340,699 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |